Erlotinib: Small-molecule targeted therapy in the treatmentof non-small-cell lung cancer
- 1 October 2005
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 27 (10) , 1513-1534
- https://doi.org/10.1016/j.clinthera.2005.10.014
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell LinesClinical Cancer Research, 2005
- Erlotinib hydrochlorideNature Reviews Drug Discovery, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- In BriefJNCI Journal of the National Cancer Institute, 2004
- Treatment of Patients with Advanced Lung Cancer and Poor Performance StatusClinical Lung Cancer, 2004
- HER-Targeted Tyrosine-Kinase InhibitorsOncology, 2002
- Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.Journal of Clinical Oncology, 1997
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- The Role of Surgery in N2 Lung CancerSurgical Clinics of North America, 1987